| Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)- RFA-OD-22-009 |
R01
|
April 05, 2022 |
July 02, 2024 |
| Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)- RFA-AI-22-025 |
R01
|
March 29, 2022 |
August 04, 2022 |
| NIAID Research Education Program (R25 Clinical Trial Not Allowed)- PAR-22-134 |
R25
|
March 15, 2022 |
October 10, 2024 |
| Limited Competition—Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)- RFA-HL-23-007 |
K38
|
March 14, 2022 |
January 11, 2025 |
| Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)- RFA-AI-22-022 |
R61/R33
|
March 10, 2022 |
August 04, 2022 |
| International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)- PAR-22-118 |
R25
|
March 10, 2022 |
June 07, 2024 |
| Notice of Special Interest (NOSI)— NIAID Administrative Supplement To Promote Discovery of Medical Countermeasures Against Chemical Threats - NOT-AI-22-030 |
Supp
|
March 02, 2022 |
March 02, 2024 |
| Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed)- RFA-AI-22-016 |
R01
|
March 02, 2022 |
July 09, 2022 |
| Notice of Special Interest (NOSI)—CCRP Administrative Supplement for Collaborative Science To Synergize Chemical Medical Countermeasures Discovery and Early Development - NOT-AI-22-029 |
Supp
|
February 25, 2022 |
March 02, 2024 |
| Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)- RFA-AI-22-012 |
U01
|
February 24, 2022 |
July 02, 2022 |
| Notice of Special Interest (NOSI)—Optimizing Vascularized Composite Allograft Survival- NOT-AI-22-023 |
R21, R01
|
February 23, 2022 |
May 08, 2026 |
| NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)- PAR-22-075 |
K22
|
January 20, 2022 |
January 08, 2025 |
| Stimulating Access to Research in Residency (StARR) (R38)- RFA-HL-23-006 |
R38
|
January 19, 2022 |
May 17, 2024 |
| Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)- PAR-22-060 |
R15
|
January 10, 2022 |
January 08, 2025 |
| Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection- NOT-HL-22-004 |
R01, R21
|
December 21, 2021 |
September 08, 2025 |
| Notice of Special Interest (NOSI)—Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities- NOT-MD-22-006 |
R01
|
December 21, 2021 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Advancing Research Needed to Develop a Universal Influenza Vaccine- NOT-AI-22-013 |
R01, R21
|
December 13, 2021 |
January 08, 2025 |
| Medical Scientist Training Program (T32)- PAR-21-189 |
T32
|
December 07, 2021 |
January 26, 2024 |
| Limited Competition—Research Resource for the National Swine Resource and Research Center (U42 Clinical Trial Not Allowed)- PAR-21-356 |
U42
|
December 03, 2021 |
September 26, 2023 |
| Notice of Special Interest (NOSI)—Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional)- NOT-OD-22-030 |
Supp
|
December 02, 2021 |
January 27, 2023 |
| Notice of Special Interest (NOSI)—Research on the Health of Women of Understudied, Underrepresented, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)- NOT-OD-22-031 |
Supp
|
December 02, 2021 |
February 01, 2023 |
| Notice of Special Interest (NOSI)—Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional)- NOT-OD-22-032 |
Supp
|
December 02, 2021 |
February 01, 2024 |
| Notice of Special Interest (NOSI)—Accelerating Malaria Vaccine Discovery- NOT-AI-22-014 |
R01
|
December 01, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Molecular and Genetic Characterization of Inborn Errors of Immunity- NOT-AI-21-082 |
R01, R21
|
November 29, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Accelerating Progress in Celiac Disease Research- NOT-AI-22-004 |
Multiple |
November 23, 2021 |
January 08, 2025 |
